Tao Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 35

Top Topics

Systematic Review

Prognostic Factors

Top Venues

Journal of oncology

Cell death & disease

Journal of gastroenterology and hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Siyu Tan, Xiao Zhang, Xiaowei Guo, Guoqiang Pan, Lunjie Yan, Ziniu Ding, Ruizhe Li, Dongxu Wang, Yuchuan Yan, Zhao-Ru Dong, Tao Li
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell death & disease 15 (7) (2024)
Shi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Xiao-Rong Yang, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis. The oncologist (2024)
Siyu Tan, Xiao Zhang, Xiaowei Guo, Guoqiang Pan, Lunjie Yan, Ziniu Ding, Ruizhe Li, Dongxu Wang, Yuchuan Yan, Zhao-Ru Dong, Tao Li
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell death & disease 15 (7) (2024)
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Xiao Zhang, Xin-Chen Mao, Si-Yu Tan, Rui-Zhe Li, Dong-Xu Wang, Zhao-Ru Dong, Yu-Chuan Yan, Tao Li
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Expert review of anticancer therapy 24 (5) (2024)
Siyu Tan, Xiao Zhang, Xiaowei Guo, Guoqiang Pan, Lunjie Yan, Ziniu Ding, Ruizhe Li, Dongxu Wang, Yuchuan Yan, Zhao-Ru Dong, Tao Li
DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell death & disease 15 (7) (2024)
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Xiao Zhang, Xin-Chen Mao, Si-Yu Tan, Rui-Zhe Li, Dong-Xu Wang, Zhao-Ru Dong, Yu-Chuan Yan, Tao Li
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Expert review of anticancer therapy (2024)
Qi-Hang Cao, Hui Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Xin-Cheng Mao, Rui-Zhe Li, Guo-Qiang Pan, Xiao Zhang, Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Si-Yu Tan, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis. Journal of gastroenterology and hepatology 39 (8) (2024)
Qi-Hang Cao, Hui Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Xin-Cheng Mao, Rui-Zhe Li, Guo-Qiang Pan, Xiao Zhang, Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Si-Yu Tan, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis. Journal of gastroenterology and hepatology (2024)
Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Guo-Qiang Pan, Xiao Zhang, Xin-Chen Mao, Si-Yu Tan, Rui-Zhe Li, Dong-Xu Wang, Zhao-Ru Dong, Yu-Chuan Yan, Tao Li
The effect of age, sex, and eastern cooperative oncology group performance status on the efficacy and safety of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Expert review of anticancer therapy 24 (5) (2024)
Shi-Jia Liu, Lun-Jie Yan, Han-Chao Wang, Zi-Niu Ding, Hui Liu, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Xiao-Rong Yang, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis. The oncologist (2024)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Siyu Tan, Zehua Wang, Na Li, Xiaowei Guo, Yankun Zhang, Hongxin Ma, Xueqi Peng, Ying Zhao, Chunyang Li, Lifen Gao, Tao Li, Xiaohong Liang, Chunhong Ma
Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response. Cell death and differentiation (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Chen Xiong, Guoqiang Pan, Hanchao Wang, Guangxiao Meng, Lunjie Yan, Ruizhe Li, Yuchuan Yan, Yafei Yang, Xiao Zhang, Chuncheng Yang, Zhaoru Dong, Tao Li
Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma. Journal of cancer research and clinical oncology (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Yu-Chuan Yan, Guang-Xiao Meng, Chun-Cheng Yang, Ya-Fei Yang, Si-Yu Tan, Lun-Jie Yan, Zi-Niu Ding, Yun-Long Ma, Zhao-Ru Dong, Tao Li
Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity. Cell death & disease 14 (7) (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Kang Wang, Hongfei Zhu, Hongming Yu, Yuqiang Cheng, Yan-Jun Xiang, Zhangjun Cheng, Yang Li, Tao Li, Dongxu Wang, Zhenyu Zhu, Shu-Qun Cheng
Early Experience of TACE Combined with Atezolizumab plus Bevacizumab for Patients with Intermediate-Stage Hepatocellular Carcinoma beyond Up-to-Seven Criteria: A Multicenter, Single-Arm Study. Journal of oncology 2023 (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy (2023)
Han Li, Hui Liu, Lun-Jie Yan, Zi-Niu Ding, Xiao Zhang, Guo-Qiang Pan, Cheng-Long Han, Bao-Wen Tian, Si-Yu Tan, Zhao-Ru Dong, Dong-Xu Wang, Yu-Chuan Yan, Tao Li
Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis. Expert review of gastroenterology & hepatology (2023)
Hui Liu, Chun-Cheng Yang, Yun-Long Ma, Ya-Fei Yang, Lun-Jie Yan, Zi-Niu Ding, Jun-Shuai Xue, Long-Shan Yang, Yu-Chuan Yan, Zhao-Ru Dong, Dong-Xu Wang, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis. Immunotherapy 15 (9) (2023)
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Jun-Shuai Xue, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Cheng-Long Han, Xin-Cheng Mao, Tao Li
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy 14 (18) (2022)
Lun-Jie Yan, Sheng-Yu Yao, Hai-Chao Li, Guang-Xiao Meng, Kai-Xuan Liu, Zi-Niu Ding, Jian-Guo Hong, Zhi-Qiang Chen, Zhao-Ru Dong, Tao Li
Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis. Journal of clinical and translational hepatology 10 (5) (2022)
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Jun-Shuai Xue, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Cheng-Long Han, Xin-Cheng Mao, Tao Li
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy (2022)
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Jun-Shuai Xue, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Cheng-Long Han, Xin-Cheng Mao, Tao Li
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy 14 (18) (2022)
Cheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan, Guang-Xiao Meng, Chun-Cheng Yang, Hui Liu, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen, Tao Li
Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades. Journal of cancer research and clinical oncology (2022)
Xiaowei Guo, Siyu Tan, Tixiao Wang, Renhui Sun, Shuangjie Li, Panpan Tian, Mengzhen Li, Yuzhen Wang, Yankun Zhang, Yuchuan Yan, Zhaoru Dong, Lunjie Yan, Xuetian Yue, Zhuanchang Wu, Chunyang Li, Kazuya Yamagata, Lifen Gao, Chunhong Ma, Tao Li, Xiaohong Liang
NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity. Hepatology (Baltimore, Md.) (2022)
Bao-Wen Tian, Cheng-Long Han, Zhao-Ru Dong, Si-Yu Tan, Dong-Xu Wang, Tao Li
Role of Exosomes in Immunotherapy of Hepatocellular Carcinoma. Cancers 14 (16) (2022)
Hui Liu, Xiao-Li Yang, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Tao Li
Clinical benefits of direct-acting antivirals therapy in hepatitis C virus patients with hepatocellular carcinoma: A systematic review and meta-analysis. Journal of gastroenterology and hepatology 37 (9) (2022)
Bao-Wen Tian, Ya-Fei Yang, Chun-Cheng Yang, Lun-Jie Yan, Zi-Niu Ding, Hui Liu, Jun-Shuai Xue, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Cheng-Long Han, Xin-Cheng Mao, Tao Li
Systemic immune-inflammation index predicts prognosis of cancer immunotherapy: systemic review and meta-analysis. Immunotherapy 14 (18) (2022)
Jun-Shuai Xue, Hui Liu, Guang-Xiao Meng, Zi-Niu Ding, Lun-Jie Yan, Sheng-Yu Yao, Hai-Chao Li, Zhao-Ru Dong, Zhi-Qiang Chen, Jian-Guo Hong, Tao Li
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis. Cancer immunology, immunotherapy : CII (2021)
Lun-Jie Yan, Sheng-Yu Yao, Guang-Xiao Meng, Kai-Xuan Liu, Hai-Chao Li, Zi-Niu Ding, Zhao-Ru Dong, Jian-Guo Hong, Zhi-Qiang Chen, Tao Li
Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Hepatology international 15 (6) (2021)
Zhao-Ru Dong, Yan-Ni Xia, Yue-Yi Zhao, Rui Wu, Kai-Xuan Liu, Kai Shi, Lun-Jie Yan, Cheng-Yu Yao, Yu-Chuan Yan, Tao Li
Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report. BMC gastroenterology 19 (1) (2019)
Xue-Feng Liu, Zhiqiang Chen, Meng Yu, Wei Zhou, Xuting Zhi, Tao Li
Safety of Simultaneous Hepatectomy and Splenectomy in the Treatment of Hepatocellular Carcinoma Complicated with Hypersplenism: A Meta-analysis. Gastroenterology research and practice 2019 (2019)